Methylmalonic Acidemia: Neurodevelopment and Neuroimaging

Overview

Journal Front Neurosci

Date 2023 Feb 13

PMID 36777632

Authors

Tao Chen

Yian Gao

Shengdong Zhang

Yuanyuan Wang

Chaofan Sui

Linfeng Yang

Affiliations

Soon will be listed here.

Abstract

Methylmalonic acidemia (MMA) is a genetic disease of abnormal organic acid metabolism, which is one of the important factors affecting the survival rate and quality of life of newborns or infants. Early detection and diagnosis are particularly important. The diagnosis of MMA mainly depends on clinical symptoms, newborn screening, biochemical detection, gene sequencing and neuroimaging diagnosis. The accumulation of methylmalonic acid and other metabolites in the body of patients causes brain tissue damage, which can manifest as various degrees of intellectual disability and severe neurological dysfunction. Neuroimaging examination has important clinical significance in the diagnosis and prognosis of MMA. This review mainly reviews the etiology, pathogenesis, and nervous system development, especially the neuroimaging features of MMA.

Citing Articles

Biotin-Thiamine-Responsive Basal Ganglia Disease: A Case Report.

Tse J, Abu-Qamar A, Youssef O, Pejka S Case Rep Neurol. 2025; 17(1):1-8.

PMID: 39981030 PMC: 11781812. DOI: 10.1159/000542886.

Clinical spectrum and genetic variation of six patients with methylmalonic aciduria (MMA); a report from Iran.

Beyzaei Z, Moravej H, Imanieh M, Inaloo S, Geramizadeh B BMC Pediatr. 2024; 24(1):795.

PMID: 39633313 PMC: 11616211. DOI: 10.1186/s12887-024-05291-z.

Associations between elevated uric acid and brain imaging abnormalities in pediatric patients with methylmalonic acidemia under 5 years of age.

Du M, Wu S, Chen Y, Yuan S, Dong S, Wang H Sci Rep. 2024; 14(1):23992.

PMID: 39402119 PMC: 11473513. DOI: 10.1038/s41598-024-74710-z.

Immune remodulation in pediatric inherited metabolic liver diseases.

Wu Y, Xiang X, Yong J, Li M, Li L, Lv Z World J Hepatol. 2024; 16(9):1258-1268.

PMID: 39351516 PMC: 11438594. DOI: 10.4254/wjh.v16.i9.1258.

Disruption of Mitochondrial Quality Control in Inherited Metabolic Disorders.

Marcuzzo M, de Andrade Silveira J, Streck E, Vockley J, Leipnitz G Mol Neurobiol. 2024; .

PMID: 39251562 DOI: 10.1007/s12035-024-04467-z.

References

Morel C, Lerner-Ellis J, Rosenblatt D . Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab. 2006; 88(4):315-21. DOI: 10.1016/j.ymgme.2006.04.001. View

Michel S, Given 2nd C, Robertson Jr W . Imaging of the brain, including diffusion-weighted imaging in methylmalonic acidemia. Pediatr Radiol. 2004; 34(7):580-2. DOI: 10.1007/s00247-004-1155-2. View

Thauvin-Robinet C, Roze E, Couvreur G, Horellou M, Sedel F, Grabli D . The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry. 2008; 79(6):725-8. DOI: 10.1136/jnnp.2007.133025. View

Herrmann W, Knapp J . Hyperhomocysteinemia: a new risk factor for degenerative diseases. Clin Lab. 2002; 48(9-10):471-81. View

Gropman A, Anderson A . Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism. J Transl Genet Genom. 2022; 4:429-445. PMC: 9075742. DOI: 10.20517/jtgg.2020.09. View

Zhang Y, Song J, Liu P, Yan R, Dong J, Yang Y . [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia]. Zhonghua Er Ke Za Zhi. 2007; 45(7):513-7. View

Randon D, Sperb-Ludwig F, Vianna F, Becker A, Vargas C, Sitta A . Prevalence of the most common pathogenic variants in three genes for inborn errors of metabolism associated with sudden unexpected death in infancy: a population-based study in south Brazil. Genet Mol Biol. 2020; 43(3):20190298. PMC: 7380325. DOI: 10.1590/1678-4685-GMB-2019-0298. View

Trinh B, Melhem E, Barker P . Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. AJNR Am J Neuroradiol. 2001; 22(5):831-3. PMC: 8174958. View

Carrillo-Carrasco N, Chandler R, Venditti C . Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis. 2011; 35(1):91-102. PMC: 4219318. DOI: 10.1007/s10545-011-9364-y. View

10.

Greitz D, Greitz T, Hindmarsh T . A new view on the CSF-circulation with the potential for pharmacological treatment of childhood hydrocephalus. Acta Paediatr. 1997; 86(2):125-32. DOI: 10.1111/j.1651-2227.1997.tb08850.x. View

11.

Rossi A, Cerone R, Biancheri R, Gatti R, Schiaffino M, Fonda C . Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. AJNR Am J Neuroradiol. 2001; 22(3):554-63. PMC: 7976836. View

12.

Burlina A, Manara R, Calderone M, Catuogno S, Burlina A . Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria. J Inherit Metab Dis. 2003; 26(5):417-22. DOI: 10.1023/a:1025106909213. View

13.

Heringer J, Valayannopoulos V, Lund A, Wijburg F, Freisinger P, Baric I . Impact of age at onset and newborn screening on outcome in organic acidurias. J Inherit Metab Dis. 2015; 39(3):341-353. DOI: 10.1007/s10545-015-9907-8. View

14.

Harting I, Seitz A, Geb S, Zwickler T, Porto L, Lindner M . Looking beyond the basal ganglia: the spectrum of MRI changes in methylmalonic acidaemia. J Inherit Metab Dis. 2008; 31(3):368-78. DOI: 10.1007/s10545-008-0801-5. View

15.

Mink J . The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol. 2003; 60(10):1365-8. DOI: 10.1001/archneur.60.10.1365. View

16.

Molema F, Haijes H, Janssen M, Bosch A, van Spronsen F, Mulder M . High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome. Clin Nutr. 2021; 40(5):3622-3630. DOI: 10.1016/j.clnu.2020.12.027. View

17.

Kolker S, Valayannopoulos V, Burlina A, Sykut-Cegielska J, Wijburg F, Leao Teles E . The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015; 38(6):1059-74. DOI: 10.1007/s10545-015-9840-x. View

18.

Liu M, Yang Y, Chang Y, Chiang S, Lin S, Han L . Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria. J Hum Genet. 2010; 55(9):621-6. DOI: 10.1038/jhg.2010.81. View

19.

Han L, Wu S, Han F, Gu X . Insights into the molecular mechanisms of methylmalonic acidemia using microarray technology. Int J Clin Exp Med. 2015; 8(6):8866-79. PMC: 4538064. View

20.

Weisfeld-Adams J, Bender H, Miley-Akerstedt A, Frempong T, Schrager N, Patel K . Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013; 110(3):241-7. DOI: 10.1016/j.ymgme.2013.07.018. View